EP3338779
LENVATINIB IN COMBINATION WITH ETOPOSIDE AND IFOSFAMIDE FOR USE IN TREATING A TUMOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.8.2016EP published:
30.6.2021EP application number:
16837150.8
EPO information:
European Patent Register
Max expiry date:
17.8.2036
Title:
LENVATINIB IN COMBINATION WITH ETOPOSIDE AND IFOSFAMIDE FOR USE IN TREATING A TUMOR
Timeline
Today
18.8.2016EP application
30.6.2021EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP
Inventor
Name:
OKAMOTO, KiyoshiAddress:
Tokyo 112-8088, JP
Name:
MATSUI, JunjiAddress:
Tsukuba-shi Ibaraki 300-2635, JP
Name:
DUTCUS, CorinaAddress:
Woodcliff Lake, New Jersey 07677, US
Priority
Number:
201562207546 PDate:
20.8.2015Country:
US
Classification
Categories:
A61K 31/47, A61K 31/675, A61K 31/7048, A61P 35/00